Hawaii Clinical Research Honolulu, HI - 96817

Hawaii Clinical Research is categorized under Business Management Consultants in Honolulu, HI and active since 1979.

Hawaii Clinical Research was established in 1979, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Business Management Consultants business, which does work in the B2B market, and is classified as a Business Management Consultants, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact Denis Mee-Lee, Owner at the company’s single location by writing to 928 Nuuanu Avenue # 2, Honolulu, Hawaii HI 96817 or by phoning (808) 538-2800. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Hawaii Clinical Research
Contact Person: Denis Mee-Lee, Owner
Address: 928 Nuuanu Avenue # 2, Honolulu, Hawaii 96817
Phone Number: (808) 538-2800
Annual Revenue (USD): $1.000.000 to $2.499.999
Founded: 1979
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Business Management Consultants
SIC Code: 8742
NAICS Code: 6211110
Share This Business:

Hawaii Clinical Research was started in 1979 to provide professional Business Management Consultants under the SIC code 8742 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.

Feel free to contact Denis Mee-Lee, Owner for inquiries that concern Hawaii Clinical Research by calling the company number (808) 538-2800, as your correspondence is most welcome. Additionally, the physical location of the single location of Hawaii Clinical Research can be found at the coordinates 21.31039,-157.86334 as well as the street address 928 Nuuanu Avenue # 2 in Honolulu, Hawaii 96817.

For its online presence, you may visit Hawaii Clinical Research’s website at and engage with its social media outlets through on Twitter and on Facebook.